Jon Napitupulu

Narsoplimab, a first-in-class antibody targeting MASP-2, the effector enzyme of the complement lectin pathway, is under development for hematopoietic...

A recent multicenter, prospective randomized controlled clinical trial evaluated a new adaptive nomogram within the Aurora Xi Plasmapheresis System...

A groundbreaking study published in The Lancet Neurology demonstrates the ability of a novel synuclein seed amplification assay (synSAA)...

NorthStar Medical Radioisotopes and Cellectar Biosciences forged a strategic partnership which centers around the supply of non-carrier-added (n.c.a.) Actinium-225...

Laekna, a global biotechnology company specializing in metabolic and cancer drug development, has partnered with Eli Lilly and Company...

Forte Biosciences, Inc., a clinical-stage biopharmaceutical company specializing in autoimmune and related diseases, has raised $53 million in an...

Puma Biotechnology initiated its ALISertib in CAncer (ALISCA™-Breast1) Phase II trial (PUMA-ALI-1201; NCT06369285). This trial investigates alisertib combined with...

COTA, Inc., a real-world data (RWD) and analytics company specializing in oncology, and Memorial Sloan Kettering Cancer Center (MSK)...

Glox Therapeutics, a company developing precision antibiotic therapies using naturally occurring bacteriocins, has received £1 million in grant funding...

Pfizer has appointed Chris Boshoff, M.D., PhD, as its new Chief Scientific Officer and President of Research & Development,...